VRTX
VERTEX PHARMACEUTICALS INC / MA- Sector
- Health Care
- Industry
- Biotechnology
- Last price
- $483.33
- As of
Share the VRTX intelligence card
See VRTX live in the terminal
Track VRTX's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live VRTX terminal, freeActive signals for VRTX
- highINSTITUTIONAL_EXIT
Bridgewater Associates, LP cut 51% of VRTX (2026Q1)
- highTRIAL_TERMINATION
Phase 3 trial terminated early - VERTEX Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumat
- highTRIAL_TERMINATION
Phase 3 trial terminated early - VERTEX Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin
- highTRIAL_TERMINATION
Phase 3 trial terminated early - VERTEX A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Thera
- highTRIAL_TERMINATION
Phase 3 trial terminated early - VERTEX Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinom
Top institutional holders of VRTX (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $288.2M | 0.38% | , |
| RENAISSANCE TECHNOLOGIES LLC | $229M | 0.36% | -31.4% |
| RENAISSANCE TECHNOLOGIES LLC | $188.3M | 0.29% | -16.5% |
| D. E. Shaw & Co., Inc. | $111.2M | 0.07% | +652.1% |
| CITADEL ADVISORS LLC | $53.3M | 0.01% | , |
| CITADEL ADVISORS LLC | $51.9M | 0.01% | -15.8% |
| MILLENNIUM MANAGEMENT LLC | $28.5M | 0.01% | +25.3% |
| MILLENNIUM MANAGEMENT LLC | $24.4M | 0.01% | -13.1% |
| MILLENNIUM MANAGEMENT LLC | $19.6M | 0.01% | , |
| Bridgewater Associates, LP | $15M | 0.06% | , |
| D. E. Shaw & Co., Inc. | $15M | 0.01% | +1659.7% |
| Bridgewater Associates, LP | $12.5M | 0.05% | -28.3% |
| Bridgewater Associates, LP | $6M | 0.03% | -51.4% |
| Point72 Asset Management, L.P. | $3.2M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $1.9M | 0.00% | , |
| Point72 Asset Management, L.P. | $1.6M | 0.00% | -49.3% |
| D. E. Shaw & Co., Inc. | $737K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $447K | 0.00% | -75.9% |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, VRTX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more VRTX signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to VRTXand get the insider, 13F, options, and confluence read in one view.